does noom offer semaglutide Med Noom Debuts Microdose GLP-1 Program
Description
SEATTLE &mdash
Why did you decide to create a GLP-1 supplement
FLOW investigators studied the effects of semaglutide (Ozempic, 1 mg/week) versus placebo in patients with type 2 diabetes and chronic kidney disease (low GFR and urine microalbumin)
Effects were linked to BMI but not observed in non-overweight participants during short-term exposure.
Zepbound crossed $1B in under a year
